+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

RANKL increases vascular smooth muscle cell calcification through a RANK-BMP4-dependent pathway

RANKL increases vascular smooth muscle cell calcification through a RANK-BMP4-dependent pathway

Circulation Research 104(9): 1041-1048

Vascular calcification commonly associated with several pathologies and it has been suggested to be similar to bone mineralization. The axis RANKL-OPG (receptor activator of nuclear factor kappaB ligand-osteoprotegerin) finely controls bone turnover. RANKL has been suggested to increase vascular calcification, but direct evidence is missing. Thus, in the present work, we assess the effect of RANKL in vascular smooth muscle cell (VSMC) calcification. VSMCs incubated with RANKL showed a dose-dependent increase in calcification, which was abolished by coincubation with OPG. To test whether the effect was mediated by signaling to its receptor, knockdown of RANK was accomplished by short hairpin (sh)RNA. Indeed, cells lacking RANK showed no increases in vascular calcification when incubated with RANKL. To further elucidate the mechanism by which RANK activation increases calcification, we blocked both nuclear factor (NF)-kappaB activation pathways. Only IKKalpha inactivation inhibited calcification, pointing to an involvement of the alternative NF-kappaB activation pathway. Furthermore, RANKL addition increased bone morphogenetic protein (BMP)4 expression in VSMCs, and that increase disappeared in cells lacking RANK or IKKalpha. The increase in calcification was also blunted by Noggin, pointing to a mediation of BMP4 in the calcification induced by RANKL. Furthermore, in an in vivo model, the increase in vascular calcium content was parallel to an increase in RANKL and BMP4 expression, which was localized in calcified areas. However, blood levels of the ratio RANKL/OPG did not change. We conclude that RANKL increases vascular smooth muscle cell calcification by binding to RANK and increasing BMP4 production through activation of the alternative NF-kappaB pathway.

(PDF emailed within 0-6 h: $19.90)

Accession: 055333169

Download citation: RISBibTeXText

PMID: 19325147

DOI: 10.1161/CIRCRESAHA.108.189001

Related references

Long Term Effect of High Glucose and Phosphate Levels on the OPG/RANK/RANKL/TRAIL System in the Progression of Vascular Calcification in rat Aortic Smooth Muscle Cells. Korean Journal of Physiology & Pharmacology 19(2): 111-118, 2015

Insulin attenuates vascular smooth muscle calcification but increases vascular smooth muscle cell phosphate transport. Atherosclerosis 195(1): E65-E75, 2007

Ovariectomy increases vascular calcification via the OPG/RANKL cytokine signalling pathway. European Journal of Clinical Investigation 38(4): 211-217, 2008

TLR2 Promotes Vascular Smooth Muscle Cell Chondrogenic Differentiation and Consequent Calcification Via the Concerted Actions of Osteoprotegerin Suppression and IL-6-Mediated RANKL Induction. Arteriosclerosis, Thrombosis, and Vascular Biology 2019: Atvbaha118311874-Atvbaha118311874, 2019

Indoxyl sulfate promotes vascular smooth muscle cell calcification via the JNK/Pit-1 pathway. Renal Failure (): 1-9, 2016

Tyrosine kinase receptors inhibit expression of smooth muscle alpha-actin in vascular smooth muscle cell through a ras-dependent pathway not involving RAF-1. Journal of the American Society of Nephrology 5(3): 722, 1994

High glucose promotes vascular smooth muscle cell calcification by activating WNT signaling pathway. Nan Fang Yi Ke Da Xue Xue Bao 35(1): 29-33, 2015

MicroRNA-34b/c inhibits aldosterone-induced vascular smooth muscle cell calcification via a SATB2/Runx2 pathway. Cell and Tissue Research 366(3): 733-746, 2016

Osteoprotegerin inhibits calcification of vascular smooth muscle cell via down regulation of the Notch1-RBP-Jκ/Msx2 signaling pathway. Plos One 8(7): E68987-E68987, 2014

Vitamin K2 inhibits rat vascular smooth muscle cell calcification by restoring the Gas6/Axl/Akt anti-apoptotic pathway. Molecular and Cellular Biochemistry 433(1-2): 149-159, 2017

Role of the sodium-dependent phosphate cotransporter, Pit-1, in vascular smooth muscle cell calcification. Circulation Research 98(7): 905-912, 2006

No influence of OPG and its ligands, RANKL and TRAIL, on proliferation and regulation of the calcification process in primary human vascular smooth muscle cells. Molecular and Cellular Endocrinology 362(1-2): 149-156, 2013

Preparation of vascular calcification in vivo and vascular smooth muscle cell calcification in vitro of rats. Beijing Da Xue Xue Bao. Yi Xue Ban 37(6): 656-658, 2005

Interleukin-24 attenuates β-glycerophosphate-induced calcification of vascular smooth muscle cells by inhibiting apoptosis, the expression of calcification and osteoblastic markers, and the Wnt/β-catenin pathway. Biochemical and Biophysical Research Communications 428(1): 50-55, 2013

Arsenic increases Pi-mediated vascular calcification and induces premature senescence in vascular smooth muscle cells. Toxicological Sciences 131(2): 641-653, 2013